Home > Insider Trading > Filing (0001179110-14-014156)

Filing Details

Accession Number:: 0001179110-14-014156
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-09-12 18:36:07
Reporting Period:: 2014-09-10

Filing Date:: 2014-09-12
Accepted Time:: 2014-09-12 18:36:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
916085	Health Net Inc	HNT	Hospital & Medical Service Plans (6324)	954288333

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1479123	Steven Sell	21650 Oxnard Street Woodland Hills CA 91367	President, West Reghealth Plan	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-09-10	44,500	$23.03	123,352	No	4	M	Direct
Common Stock	Disposition	2014-09-10	44,000	$46.47	79,352	No	4	S	Direct
Common Stock	Disposition	2014-09-10	500	$47.14	78,852	No	4	S	Direct
Common Stock	Acquisiton	2014-09-10	23,600	$30.73	102,452	No	4	M	Direct
Common Stock	Disposition	2014-09-10	23,300	$46.47	79,152	No	4	S	Direct
Common Stock	Disposition	2014-09-10	300	$47.10	78,852	No	4	S	Direct
Common Stock	Disposition	2014-09-10	25,473	$46.45	53,379	No	4	S	Direct
Common Stock	Acquisiton	2014-09-11	11,000	$23.03	64,379	No	4	M	Direct
Common Stock	Disposition	2014-09-11	11,000	$47.00	53,379	No	4	S	Direct
Common Stock	Acquisiton	2014-09-11	11,650	$30.73	65,029	No	4	M	Direct
Common Stock	Disposition	2014-09-11	11,650	$47.00	53,379	No	4	S	Direct
Common Stock	Acquisiton	2014-09-11	1,050	$29.20	54,429	No	4	M	Direct
Common Stock	Disposition	2014-09-11	1,050	$47.00	53,379	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-10	44,500	$0.00	44,500	$23.03
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-10	23,600	$0.00	23,600	$30.73
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-11	11,000	$0.00	11,000	$23.03
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-11	11,650	$0.00	11,650	$30.73
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-11	1,050	$0.00	1,050	$29.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,100	2013-02-22	2017-02-22	No	4	M	Direct
23,400		2018-02-18	No	4	M	Direct
11,100	2013-02-22	2017-02-22	No	4	M	Direct
11,750		2018-02-18	No	4	M	Direct
0		2015-02-24	No	4	M	Direct

Footnotes

Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on February 22, 2010 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2010 Grant"), in a transaction exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Act"). The exercise of the 2010 Grant, as reported on this Form 4, was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
Includes shares held by the Steven J. Sell and Margaret D. William Revocable Trust, of which the Reporting Person is a trustee and beneficiary.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.05 to $46.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.08 to $47.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on February 18, 2011 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2011 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2011 Grant, as reported on this Form 4, was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.07 to $46.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.08 to $47.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.08 to $46.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on February 24, 2005 under the Issuer's 1998 Stock Option Plan, as amended (the "2005 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2005 Grant, as reported on this Form 4, was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The 2011 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of February 18, 2011, the grant date.
The 2005 Grant became exercisable in 25% increments on each of the first, second, third and fourth anniversaries of February 24, 2005, the grant date.